戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 atures including fasciculations and elevated serum creatine kinase.
2 ion and pathology and reduction in levels of serum creatine kinase.
3 ent, with significant reduction in levels of serum creatine kinase.
4 vere proximal weakness and markedly elevated serum creatine kinase.
5 thout causing pain or cramping or increasing serum creatine kinase.
6 are myalgias, myoglobinuria, and an elevated serum creatine kinase.
7 in muscle degeneration and concentrations of serum creatine kinase.
8 diotoxicity was evident by a 60% increase in serum creatine kinase activity and a 5-fold increase in
9 ongissimus lumborum and a 5-fold increase in serum creatine kinase activity compared with healthy mal
10 ency were a more than five times increase in serum creatine kinase activity or a >28% increase of liv
11 lly located myofiber nuclei and the level of serum creatine kinase activity were not decreased in DG/
12  damage, as evidenced by i) normal levels of serum creatine kinase activity, ii) a lack of Evans blue
13 ored contractile function and a reduction in serum creatine kinase activity.
14  Routine blood chemistry was normal, as were serum creatine kinase and aldolase levels and thyroid, h
15     Laboratory analysis showed alteration of serum creatine kinase and creatinine in the Leu389Ser AL
16 tains sarcolemmal integrity as determined by serum creatine kinase and Evans blue uptake assays, and
17  muscle damage, as evidenced by decreases in serum creatine kinase and key liver enzymes, suggesting
18 emical analysis indicated that the levels of serum creatine kinase and lactate dehydrogenase in ADR-t
19  of adult onset muscular dystrophy with high serum creatine kinase and that mutation screening, parti
20 fiber size distribution, centralized nuclei, serum creatine kinase, and quantitative histopathology s
21      All patients showed increased levels of serum creatine kinase but no or minor muscle weakness.
22                                        Total serum creatine kinase (CK) and cardiac TnT were measured
23                         In the 14-day study, serum creatine kinase (CK) dropped by 50%, which was not
24  important myositis and rhabdomyolysis, mild serum creatine kinase (CK) elevations, myalgia with and
25 between the anti-Jo-1 antibody level and the serum creatine kinase (CK) level, as well as muscle and
26                       An association between serum creatine kinase (CK) levels and the risk of kidney
27                                              Serum creatine kinase (CK) levels were lower (p = 0.025)
28                                              Serum creatine kinase (CK) levels were normal or mildly
29                                 In addition, serum creatine kinase (CK) levels within the Oxford CMS
30               Manual muscle testing results, serum creatine kinase (CK) levels, and the daily cortico
31  timed Gower score, time to run 30 feet, and serum creatine kinase [CK] level) and with nonquantitati
32 's Blue dye uptake into muscle and increased serum creatine kinase compared to the 129T2/SvEmsJ backg
33                                        Total serum creatine kinase concentrations increased significa
34  in vivo, and resulted in large decreases in serum creatine kinase concentrations.
35  rhabdomyolysis is rare, muscle symptoms and serum creatine kinase elevations are sufficiently freque
36     These symptoms may occur with or without serum creatine kinase elevations.
37 333Y mice exhibited progressive MD, elevated serum creatine kinase, heart dilation, blood vessel irre
38                                              Serum creatine kinase in all patients was at least 10 ti
39 wers to why some individuals who have active serum creatine kinase in clinical assessments may not re
40            Following both trailer stressors, serum creatine kinase increased (P < 0.0001) and remaine
41                                              Serum creatine kinase is elevated and muscle histology i
42                                              Serum creatine kinase level can be normal or only mildly
43 ity P = 0.45; I2 = 0%), and increases in the serum creatine kinase level were reduced (OR, 0.72 [CI,
44 g scale) of disease activity, the MMT score, serum creatine kinase level, and the Juvenile Arthritis
45 int contractures, severe scoliosis, elevated serum creatine kinase level, myopathic electrodiagnostic
46 leakiness throughout the body and normalized serum creatine kinase levels (a 50- to 100-fold drop).
47                                    Decreased serum creatine kinase levels (significant improvement fo
48 terized by adult onset muscle weakness, high serum creatine kinase levels and a prominent inflammator
49 in muscle degeneration, but had no effect on serum creatine kinase levels and muscle strength.
50 s less, Evans blue dye uptake is reduced and serum creatine kinase levels are lower.
51 ot associated with an increased incidence of serum creatine kinase levels that were more than 10 time
52 obands' muscle biopsies were dystrophic, and serum creatine kinase levels were 1,050 to 9,200U/l.
53 ber central nucleation, tissue fibrosis, and serum creatine kinase levels were dramatically reduced i
54                                 Furthermore, serum creatine kinase levels were greater in SCT at pre-
55 rs after MDMA treatment, blood was drawn and serum creatine kinase levels were measured as a marker o
56                                              Serum creatine kinase levels were normal in family membe
57                               Muscle MRI and serum creatine kinase levels were normal.
58                                              Serum creatine kinase levels were usually moderately hig
59  size distribution and significantly reduced serum creatine kinase levels, but had limited effect on
60        In addition, these mice show elevated serum creatine kinase levels, consistent with the myo-ne
61 muscle of Dmdmdx-5Cv mice results in reduced serum creatine kinase levels, improved sarcolemmal integ
62     This was associated with greatly reduced serum creatine kinase levels, near-normal histology, and
63 type but without an earlier onset, increased serum creatine kinase levels, or decreased muscle streng
64 ular dystrophy by several standard measures; Serum creatine kinase levels, percentage of centrally lo
65 etic resonance imaging, and through elevated serum creatine kinase levels.
66  enhanced interstitial fibrosis and elevated serum creatine kinase levels.
67 , less Evans blue dye infiltration and lower serum creatine kinase levels.
68 rent abdominal pain, and moderately elevated serum creatine kinase levels.
69 y as determined by muscle histopathology and serum creatine kinase levels.
70 thologic findings of myopathy despite normal serum creatine kinase levels.
71 habdomyolysis, and persistent basal elevated serum creatine kinase levels.
72                                 We monitored serum creatine kinase levels; changes in peak cycle work
73 value of serum levels of cardiac troponin T, serum creatine kinase MB (CK-MB) levels, and electrocard
74                                 Elevation of serum creatine kinase MB fraction (CK-MB) after percutan
75                                              Serum creatine kinase-MB (CK-MB) and cardiac troponin T
76 dial infarction </=1 flow, there was reduced serum creatine kinase (P=0.030) and a 19% reduction in c
77 tatin, but not pravastatin, induced elevated serum creatine kinase; swollen, misaligned, size-variabl
78 ntegrin, stabilized the sarcolemma, restored serum creatine kinase to wild-type levels, and protected
79 ximal lower limb weakness with highly raised serum creatine kinase values (average 4500 IU/l) and fre
80 ion of muscular dystrophy or persistent high serum creatine kinase values (hyperCKemia).
81                                              Serum creatine kinase values were usually normal or slig
82                                              Serum creatine kinase was usually mildly elevated (363 +